Literature DB >> 20171676

Gadolinium enhanced magnetic resonance urography for upper urinary tract malignancy.

Naoki Takahashi1, James F Glockner, Robert P Hartman, Bernard F King, Bradley C Leibovich, David W Stanley, Patrick D Fitz-Gibbon, Akira Kawashima.   

Abstract

PURPOSE: We retrospectively evaluated the accuracy of gadolinium enhanced magnetic resonance urography to detect upper urinary tract tumors.
MATERIALS AND METHODS: A total of 91 magnetic resonance urography studies for suspected upper tract malignancy were done in 70 males and 18 females with a mean age of 71.7 years. Breath hold coronal T2-weighted single shot fast spin-echo and breath-hold coronal 3-dimensional T1-weighted spoiled gradient-recalled echo images with fat suppression were obtained during the nephrographic and excretory phases after intravenous injection of gadolinium based contrast material. Two radiologists independently reviewed magnetic resonance images for a tumor by 4 regions (right/left and renal collecting system/ureter). Sensitivity, specificity and accuracy were calculated.
RESULTS: A total of 35 urinary tract regions in 18 males and 7 females with a mean age of 70.4 years were confirmed to have an upper tract malignant tumor and 219 urinary tract regions were confirmed to be tumor-free. Sensitivity, specificity and accuracy to detect upper urinary tract malignancy were 74.3%, 96.8% and 93.7% for reviewer 1, and 62.9%, 96.3% and 91.7% for reviewer 2, respectively. When patients with a ureteral stent or nephrostomy tube were excluded from analysis, sensitivity, specificity and accuracy were 86.2%, 99.5% and 97.7% for reviewer 1, and 72.4%, 97.9% and 94.6% for reviewer 2, respectively.
CONCLUSIONS: Gadolinium enhanced magnetic resonance urography is accurate to detect upper urinary tract malignant tumors. Copyright (c) 2010 American Urological Association Education and Research, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20171676     DOI: 10.1016/j.juro.2009.12.031

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  10 in total

1.  [Oncological diseases and postoperative alterations of the bladder and urinary tract].

Authors:  M M Ong; P Riffel; J Budjan; C Bolenz; S O Schönberg; S Haneder
Journal:  Radiologe       Date:  2014-12       Impact factor: 0.635

2.  [Elective organ and function preservation in ureter and renal pelvis tumors].

Authors:  S Rausch; G Gakis; J Bedke; A Stenzl
Journal:  Urologe A       Date:  2014-09       Impact factor: 0.639

Review 3.  Upper tract urothelial carcinoma: Paradigm shift towards nephron sparing management.

Authors:  Julia V Fiuk; Brad F Schwartz
Journal:  World J Nephrol       Date:  2016-03-06

Review 4.  [Microscopic hematuria : Reasonable and risk-adapted diagnostic evaluation].

Authors:  N Löbig; F Wezel; T Martini; B Schröppel; C Bolenz
Journal:  Urologe A       Date:  2017-09       Impact factor: 0.639

5.  Trends in the utilization of imaging for upper tract urothelial carcinoma.

Authors:  Anand Mohapatra; Goutham Vemana; Sam Bhayani; Jack Baty; Joel Vetter; Seth A Strope
Journal:  Urol Oncol       Date:  2016-01-21       Impact factor: 3.498

6.  Collecting duct carcinoma of the kidney: Imaging observations of a rare tumor.

Authors:  Yuxiao Hu; Guang-Ming Lu; Kai Li; Long-Jiang Zhang; Hong Zhu
Journal:  Oncol Lett       Date:  2013-12-06       Impact factor: 2.967

Review 7.  MicroRNA Signatures in the Upper Urinary Tract Urothelial Carcinoma Scenario: Ready for the Game Changer?

Authors:  Alessandra Cinque; Anna Capasso; Riccardo Vago; Matteo Floris; Michael W Lee; Roberto Minnei; Francesco Trevisani
Journal:  Int J Mol Sci       Date:  2022-02-26       Impact factor: 5.923

8.  Comprehensive MR Urography Protocol: Equally Good Diagnostic Performance and Enhanced Visibility of the Upper Urinary Tract Compared to Triple-Phase CT Urography.

Authors:  Mazen Sudah; Amro Masarwah; Sakari Kainulainen; Marja Pitkänen; Hanna Matikka; Vaiva Dabravolskaite; Sirpa Aaltomaa; Ritva Vanninen
Journal:  PLoS One       Date:  2016-07-06       Impact factor: 3.240

Review 9.  Advances in risk stratification of bladder cancer to guide personalized medicine.

Authors:  Justin T Matulay; Ashish M Kamat
Journal:  F1000Res       Date:  2018-07-25

Review 10.  Non-Invasive Biomarkers in the Diagnosis of Upper Urinary Tract Urothelial Carcinoma-A Systematic Review.

Authors:  Łukasz Białek; Konrad Bilski; Jakub Dobruch; Wojciech Krajewski; Tomasz Szydełko; Piotr Kryst; Sławomir Poletajew
Journal:  Cancers (Basel)       Date:  2022-03-16       Impact factor: 6.639

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.